Stock VENTRUS BIOSCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Ventrus Biosciences Inc Nasdaq

Equities

US9228221019

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Ventrus Biosciences Inc
Mar. 28 Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 19 Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing MT

Chart calendar Ventrus Biosciences Inc

57dea0533a.6Tm5G9QwmiZmvd4at81VrLa2e0bolj0OdNs1-ljBk_w.mg3VNp1orEMC7LVsmpQbye_4NymP2GV8MqhUpR6s56XaUfBd4l3ZUwvtqQ~247a5e590fa7cede581e4ef7237664a8

Upcoming events on Ventrus Biosciences Inc

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-05 Q4 2024 Earnings Release (Projected)

Past events on Ventrus Biosciences Inc

2024-03-28 04:05 pm Q4 2023 Earnings Release
2024-02-11 Reverse Split: 1 of 12
2024-01-31 11:00 am Extraordinary Shareholders Meeting
2023-11-12 08:30 am AASLD Liver Meeting
2023-11-10 12:00 pm AASLD Liver Meeting - Poster Number: 1474-C
2023-11-08 04:05 pm Q3 2023 Earnings Release
2023-10-17 08:30 am Business Update Call
2023-09-21 10:00 pm International HBV Meeting
2023-09-20 04:15 am International HBV Meeting
2023-09-20 02:30 am International HBV Meeting
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-07-14 International Herpesvirus Workshop
2023-06-24 03:00 am EASL International Liver Congress - Poster NO-186
2023-06-24 03:00 am EASL International Liver Congress - Poster NO-168
2023-06-24 03:00 am EASL International Liver Congress - Poster NO-195
2023-06-24 03:00 am EASL International Liver Congress - Poster No-174
2023-06-21 03:00 am European Association for the Study of the Liver Congress - Poster NO-114
2023-06-20 European Association for the Study of the Liver Congress
2023-06-07 04:00 pm Jefferies Global Healthcare Conference
2023-06-01 Science of HBV Cure Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		16,0
14,8
7.82%		79,1
82,0
-3.54%		6,25
6,16
1.5%		0,00
0,00
- 		7,16
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-103
-104
0.93%		-64,8
-52,0
-24.5%		-91,1
-91,0
-0.09%		-94,1
-93,2
-1.02%		-64,6
-68,6
5.76%
-84,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-98,4
-98,6
0.21%		-62,2
-53,7
-15.75%		-132
-90,7
-45.9%		-93,1
-92,9
-0.15%		-61,2
-66,1
7.37%
-81,8

Net income
Million USD		Released
Forecast
Spread 		-97,6
-98,6
0.99%		-62,2
-53,7
-15.75%		-130
-90,8
-43.06%		-93,1
-92,9
-0.15%		-61,2
-66,1
7.32%
-81,8

EPS
USD		Released
Forecast
Spread 		-44,6
-44,9
0.67%		-21,0
-18,7
-12.47%		-36,0
-25,3
-42.52%		-23,0
-23,0
-0.26%		-13,4
-14,3
6.3%
-14,9

Announcement Date04/03/2025/02/2111/03/2222/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
1,25
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		7,16
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-21,3
-22,1
3.93%		-23,2
-21,0
-10.09%		-24,6
-23,8
-3.25%		-23,4
-26,1
10.34%		-23,0
-27,2
15.52%		-19,6
-17,8
-10.19%		-17,5
-15,5
-12.83%		-15,0
-13,0
-15.75%		-12,6
-16,5
23.93%
-18,3


-19,8


-22,0


-24,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-62,8
-21,8
-188.18%		-23,1
-21,0
-10.06%		-24,5
-23,8
-2.92%		-23,1
-26,1
11.32%		-22,4
-27,2
17.67%		-19,0
-17,4
-8.75%		-16,9
-15,2
-11.34%		-14,4
-12,3
-17.24%		-10,9
-15,8
30.83%
-17,6


-19,1


-21,3


-23,8

Net income
Million USD		Released
Forecast
Spread 		-60,3
-21,8
-176.56%		-23,1
-21,0
-10.06%		-24,5
-23,8
-2.92%		-23,1
-26,1
11.32%		-22,4
-27,2
17.67%		-19,0
-17,4
-8.75%		-16,9
-15,2
-11.34%		-14,4
-12,3
-17.24%		-11,0
-15,8
30.62%
-17,6


-19,1


-21,3


-23,8

EPS
USD		Released
Forecast
Spread 		-16,4
-5,73
-186.91%		-5,76
-5,70
-1.05%		-6,12
-5,88
-4.08%		-5,76
-6,48
11.11%		-5,52
-6,72
17.86%		-4,44
-4,26
-4.23%		-3,84
-3,48
-10.34%		-3,24
-2,76
-17.39%		-1,74
-2,88
39.58%
-3,23


-3,48


-3,87


-4,30

Announcement Date11/03/2212/05/2209/08/2208/11/2222/03/2304/05/2309/08/2308/11/2328/03/24----

Upcoming sector events for Ventrus Biosciences Inc

2024-04-29 YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release
2024-04-29 SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-05-05 HK INNO.N CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-06 KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-06 KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release
2024-05-06 CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release
2024-05-08 04:05 pm SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-08 SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-05-09 OSCOTEC INC.: Q1 2024 Earnings Release (Projected)
2024-05-12 MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Ventrus Biosciences Inc

Today FRONTIER BIOTECHNOLOGIES INC.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-25 SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-25 SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-25 02:00 am INDIVIOR PLC: Q1 2024 Earnings Release
2024-04-24 CHANGCHUN BCHT BIOTECHNOLOGY CO.: Q1 2024 Earnings Release (Projected)
2024-04-23 SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. ASMB Stock
  4. Stock
  5. Calendar Ventrus Biosciences Inc